Request to Join
has invited you to join this group
Csaba P. Kovesdy, MD, is The Fred Hatch Professor of Medicine in Nephrology and Director of the Clinical Outcomes and Clinical Trials Program at the University of Tennessee Health Science Center in Memphis, Tennessee and Chief of Nephrology at the Memphis VA Medical Center in Memphis, Tennessee. Dr. Kovesdy earned his medical degree from the University of Pecs Medical School in Pecs, Hungary. He performed his residency in Internal Medicine at the Henry Ford Hospital in Detroit, MI, and completed a clinical fellowship in Nephrology at the Johns Hopkins Bayview Medical Center in Baltimore, MD.
Dr. Kovesdy’s research interests are centered on epidemiology and outcomes in pre-dialysis chronic kidney disease, including studies in the areas of hypertension, metabolic abnormalities and nutritional disorders in pre-dialysis chronic kidney disease. Dr. Kovesdy has published his research in over 375 peer-reviewed articles, as well as numerous abstracts and book chapters, and was ranked 3rd among 74,300 published authors worldwide in the topic of CKD from 2006 through 2015 by the website Expertscape (http://www.expertscape.com/ex/kidney+failure%2C+chronic). He is a Fellow of the American Society of Nephrology, and a member of the International Society of Nephrology.
Johannes F. E. Mann, M.D., is currently (since 1989) full Professor of Medicine at the University of Erlangen-Nürnberg and Head, KfH Kidney Center, Munich, both in Germany. He is also (since 2010) International Scholar at Population Health Research Institute, McMaster University, Canada. His previous assignments include Director of Dept. of Nephrology, Munich General Hospitals, staff member and assistant Professor of Medicine, Dept. of Medicine, University of Heidelberg, Germany, and research fellowships in Pharmacology at the Universities of Montreal, Canada and of Heidelberg, Germany. Professor Mann, a board-certified specialist in Internal Medicine, in Nephrology, in Intensive Care and in Pharmacology and Toxicology, was an officer of the German Societies of Medicine and of Nephrology, of the International Society of Nephrology and is on the editorial board of major journals of nephrology. His scientific work includes about 220 original paper. His H-Index is 67; his citations rank among the top 25 of European nephrologists. Some of his papers, published in Nature, NEJM, Lancet, JAMA and Ann Int Med, were cited more than 2000 times, total citations are close to 19,000. The work of Professor Mann concerned initially the physiology of the renin- angiotensin system in experimental animals and later the role of this system for diseases of the kidney, the heart, the arteries, and for diabetes and its damages. From there, his interest moved to the treatment and prevention of progressive renal diseases, including diabetic and hypertensive kidney disease. The latter included planning, steering, adjudication and DSMB memberships in pivotal large outcome trials, namely AIPRI, HOPE, MICRO-HOPE, HOPE-TOO, ONTARGET, RENAL- ONTARGET, TRANSCEND, RENAL-TRANSCEND, ASCEND, DIABHYCAR, ORIGIN, LEADER, SONAR, SOUL.
Dr. Bakris received his medical degree from the Rosalind Franklin School of Medicine and completed residency in Internal Medicine at the Mayo Graduate School of Medicine where he also completed a research fellowship in Physiology and Biophysics. He then completed fellowships in Nephrology and Clinical Pharmacology at the University of Chicago. From 1988 to 1991, he served as Director of Renal Research at the Ochsner Clinic and had faculty appointments in the Departments of Medicine and Physiology at Tulane University School of Medicine. He later was Professor and Vice Chairman of Preventive Medicine and Director of the Rush University Hypertension Center in Chicago from 1993 until 2006. Currently, he is a tenured Professor of Medicine and Director of the ASH Comprehensive Hypertension Center in the Department of Medicine at the University of Chicago Medicine. Dr. Bakris has published over 800 peer reviewed articles and book chapters in the areas of diabetic kidney disease, hypertension, and progression of nephropathy. He is the Editor or Co- Editor of 20 books, in the areas of Kidney Disease Progression and Diabetes as well as the new (2017) 3 rd edition of Hypertension: A Companion to Braunwald’s The Heart. Additionally, he is an Associate Editor of the International Textbook of Cardiology. He is a Fellow of the American College of Physicians, American Society of Nephrology, American Society of Hypertension, and the American Heart Association. He was a member of the NIH National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease (1994). He also served as a special government expert to the Cardio-renal Advisory Board of the FDA and to CMS (2012-2016). He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on kidney disease progression (1999-2000). He has also served on many national guideline committees including: The Joint National Committee Writing Groups JNC 7 (2003), the JNC 7 executive committee (2003), the American Diabetes Association Clinical Practice Guideline Committee (2002- 2004), the National Kidney Foundation (K-DOQI) Blood Pressure Guideline committee (2002-2004 & 2013), (K-DOQI) Diabetes Guideline committee (2003- 2005 & 2014), Chair, ADA Blood Pressure Consensus Report (2016-2017) and ACC/AHA writing committees for Aortic Aneurysm, Hypertension in the Elderly and Resistant Hypertension Guidelines (2006-2017). Dr. Bakris is the past-president of the American College of Clinical Pharmacology (2000-2002) and the American Society of Hypertension (ASH). He is the current Editor-in-Chief, Am J Nephrology, Editor-in-Chief- Up-to-Date, Nephrology section, Hypertension Section Editor Up-to-Date and Assoc. Ed of Diabetes Care.